Atlas Trials

The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation

RecordFirmDate
Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT (NCT05914675)Institute of Hematology & Blood Diseases Hospital, China2023-07-01

Track The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation automatically

Every clearance here is in the API, with alerts when new ones post.